Jason Fangusaro

Pediatric Neuro-Oncologist and Developmental Therapeutics Clinical Researcher

[Jason Fangusaro @fangusaro]

@AmandaHaddock @JaceWard3 I only got the great opportunity to hear about Jace from his mother and the amazing DIPG selfless groups who continue to fight so hard for change. I send my deepest thoughts to his family, friends, medical ream and the entire DIPG community. He truly was a warrior!

[PBTC Foundation @PbtcF]

Great research at work! https://t.co/1uYo74N8WS "Over 70% of children with recurrent optic pathway/hypothalamic low-grade glioma had shrinkage or stability of their tumor using selumetinib (an oral agent)."